Update on the use of fibrinolysins in pleural disease

Clinical Pulmonary Medicine

Volumn 12, Issue 3, 2005, Pages 184-190

  Idell, Steven ^a  

^a UNIVERSITY OF TEXAS HEALTH CENTER   (United States)

Author keywords

Fibrin; Fibrinolysis; Fibrosis; Loculation; Plasminogen activators; Pleural effusions; Streptokinase; Tissue plasminogen activator; Urokinase

Indexed keywords

PLASMIN; STREPTOKINASE; TISSUE PLASMINOGEN ACTIVATOR; UROKINASE;

CLINICAL RESEARCH; COST EFFECTIVENESS ANALYSIS; DRUG DOSE REGIMEN; DRUG EFFICACY; DRUG HALF LIFE; DRUG TOLERABILITY; FIBRINOLYSIS; HEMATOTHORAX; HUMAN; NONHUMAN; PLEURA EFFUSION; PLEURA EMPYEMA; PLEURAL FIBROSIS; REVIEW;

EID: 18844395402     PISSN: 10680640     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.cpm.0000163392.76738.84     Document Type: Review

References (49)

1. Idell S. Coagulation, fibrinolysis and fibrin deposition in lung injury and repair. In: Phan SH, Thrall RS, Lenfant C, eds. Pulmonary Fibrosis. New York, NY: Marcel Dekker; 1995:743-776.
2. Light RW. Update: management of parapneumonic effusions. Clin Pulm Med. 2003;10:336-342.
3. Idell S, Pendurthi U, Pueblitz S, et al. Tissue factor pathway inhibitor in tetracycline-induced pleuritis in rabbits. Thromb Haemost. 1998;79:649-655.
4. Bignon J, Gee JB. Pleural fibrogenesis. In: Lenfant C, ed. Lung Biology in Health and Disease. New York, NY: Marcel Dekker; 2001:417-443.
5. Miller EJ, Kajikawa O, Pueblitz S, et al. Chemokine involvement in tetracycline-induced pleuritis. Eur Respir J. 1999;14:1387-1393.
6. Dvorak HF. Tumors: wounds that do not heal: similarities between tumor stroma generation and wound healing [review]. N Engl J Med. 1986;315:1650-1659.
7. Dvorak HF, Senger DR, Dvorak AM, et al. Regulation of extravascular coagulation by microvascular permeability. Science. 1985;227:1059-1061.
8. Idell S, Girard W, Koenig KB, et al. Abnormalities of pathways of fibrin turnover in the human pleural space. Am Rev Respir Dis. 1991;144:187-194.
9. Idell S, Zwieb C, Kumar A, et al. Pathways of fibrin turnover of human pleural mesothelial cells in vitro. Am J Respir Cell Mol Biol. 1992;7:414-426.
10. Idell S. The fibrinolytic defect in ARDS: a therapeutic opportunity? Clin Pulm Med. In press.
11. Idell S, Mazar AP, Bitterman P, et al. Fibrin turnover in lung inflammation and neoplasia. Am J Respir Crit Care Med. 2001;163:578-584.
12. Idell S. Extravascular coagulation and fibrin deposition in acute lung injury [review]. New Horizons. 1994;2:566-574.
13. Dano K, Andreasen PA, Grondahl-Hansen J, et al. Plasminogen activators, tissue degradation, and cancer [review]. Adv Cancer Res. 1985;44:139-266.
14. Chapman HA. Plasminogen activators, integrins, and the coordinated regulation of cell adhesion and migration [review]. Curr Opin Cell Biol. 1997;9:714-724.
15. Abraham E. Coagulation abnormalities in acute lung injury and sepsis. Am J Respir Cell Mol Biol. 2000;22:401-404.
16. Vassalli JD, Sappino AP, Belin D. The plasminogen activator/plasmin system [review]. J Clin Invest. 1991;88:1067-1072.
17. Stevens T, Garcia JGN, Shasby DM, et al. Mechanisms regulating endothelial cell barrier function. Am J Lung Cell Mol Physiol. 2000;279:L419-L422.
18. Narayanan S. Multifunctional roles of thrombin. Ann Clin Lab Sci. 1999;29:275-280.
19. Philip-Joet F, Alessi MC, Philip-Joet C, et al. Fibrinolytic and inflammatory processes in pleural effusions. Eur Respir J. 1995;8:1352-1356.
20. Ingelfinger JR. Forestalling fibrosis. N Engl J Med. 2003;349:2265-2266.
21. Olman M, Mackman N, Gladson CL, et al. Changes in procoagulant and fibrinolytic gene expression during bleomycin-induced lung injury in the mouse. J Clin Invest. 1999;96:1621-1630.
22. Barazzone C, Belin D, Piguet P-F, et al. Plasminogen activator inhibitor-1 in acute hyperoxic mouse lung injury. J Clin Invest. 1996;98:2666-2673.
23. Idell S. Endothelium and disordered fibrin turnover in the injured lung: newly recognized pathways. Crit Care Med. 2002;30(5 suppl):S274-S280.
24. Idell S. Coagulation, fibrinolysis, and fibrin deposition in acute lung injury. Crit Care Med. 2003;31(4 suppl):S213-S220.
25. Tillett WS, Sherry S. The effect in patients of streptococcal fibrinolysin (streptokinase) and streptococcal desoxyribonuclease on fibrinous, purulent and sanguinous pleural exudations. J Clin Invest. 1949;28:173-190.
26. Tillett WS, Sherry S, Read CT. The use of streptokinase-streptodornase in the treatment of postpneumonic empyema. J Thorac Surg. 1951;21:275-297.
27. Bergh NP, Ekroth R, Larsson S, et al. Intrapleural streptokinase in the treatment of haemothorax and empyema. Scand J Thorac Cardiovasc Surg. 1977;11:265-268.
28. Bouros D, Schiza S, Tzanakis N, et al. Intrapleural urokinase in the treatment of complicated parapneumonic pleural effusions and empyema. Eur Respir J. 1996;9:1656-1659.
29. Bouros D, Schiza S, Patsourakis G, et al. Intrapleural streptokinase versus urokinase in the treatment of complicated parapneumonic effusions: a prospective, double-blind study. Am J Respir Crit Care Med. 1997;155:291-295.
30. Bouros D, Antoniou KM, Chalkiadakis G, et al. The role of video-assisted thoracoscopic surgery in the treatment of parapneumonic empyema after the failure of fibrinolytics. Surg Endosc. 2002;16:151-154.
31. Jerjes-Sanchez C, Ramirez-Rivera A, Elizalde JJ, et al. Intrapleural fibrinolysis with streptokinase as an adjunctive treatment in hemothorax and empyema: a multicenter trial. Chest. 1996;109:1514-1519.
32. Laisaar T, Puttsepp E, Laisaar V. Early administration of intrapleural streptokinase in the treatment of multiloculated pleural effusions and pleural empyemas. Thorac Cardiovasc Surg. 1996;44:252-256.
33. Temes RT, Follis F, Kessler RM, et al. Intrapleural fibrinolytics in management of empyema thoracis. Chest. 1996;110:102-106.
34. Basile A, Boullosa-Seoane E, Dominguez VL, et al. Intrapleural fibrinolysis in the management of empyemas and haemothoraces: our experience. Radiol Med (Torino). 2003;105:12-16.
35. Krishnan S, Amin N, Dozor AJ, et al. Urokinase in the management of complicated parapneumonic effusions in children. Chest. 1997;112:1579-1583.
36. Davies RJ, Traill ZC, Gleeson FV. Randomised controlled trial of intrapleural streptokinase in community acquired pleural infection. Thorax. 1997;52:416-421.
37. Bouros D, Schiza S, Tzanakis N, et al. Intrapleural urokinase versus normal saline in the treatment of complicated parapneumonic effusions and empyema: a randomized, double-blind study. Am J Respir Crit Care Med. 1999;159:37-42.
38. Tuncozgur B, Ustunsoy H, Sivrikoz MC, et al. Intrapleural urokinase in the management of parapneumonic empyema: a randomised controlled trial. Int J Clin Pract. 2001;55:658-660.
39. Chin NK, Lim TK. Controlled trial of intrapleural streptokinase in the treatment of pleural empyema and complicated parapneumonic effusions. Chest. 1997;111:275-279.
40. Cameron R. Intra-pleural fibrinolytic therapy vs. conservative management in the treatment of parapneumonic effusions and empyema. Cochrane Database Syst Rev. 2000;(3):CD002312.
41. Davies CW, Lok S, Davies RJ. The systemic fibrinolytic activity of intrapleural streptokinase. Am J Respir Crit Care Med. 1998;157:328-330.
42. Sahn SA. Use of fibrinolytic agents in the management of complicated parapneumonic effusions and empyemas. Thorax. 1998;53(suppl 2):S65-S72.
43. Walker CA, Shirk MB, Tschampel MM, et al. Intrapleural alteplase in a patient with complicated pleural effusion. Ann Pharmacother. 2003;37:376-379.
44. Idell S, Mazar A, Cines D, et al. Single-chain urokinase alone or complexed to its receptor in tetracycline-induced pleuritis in rabbits. Am J Respir Crit Care Med. 2002;166:920-926.
45. Strange C, Baumann MH, Sahn SA, et al. Effects of intrapleural heparin or urokinase on the extent of tetracycline-induced pleural disease. Am J Respir Crit Care Med. 1995;151(2 pt 1):508-515.
46. Wells RG, Havens PL. Intrapleural fibrinolysis for parapneumonic effusion and empyema in children. Radiology. 2003;228:370-378.
47. Bishop NB, Pon S, Ushay HM, et al. Alteplase in the treatment of complicated parapneumonic effusion: a case report. Pediatrics. 2003;111:E188-E190.
48. Colice GL, Curtis A, Deslauriers J, et al. Medical and surgical treatment of parapneumonic effusions: AACP Consensus Statement. Chest. 2000;18:1158-1171.
49. Bell WR. Present day thrombolytic therapeutic agents: pharmocotherapeutics and pharmocodynamics. Rev Cardiovasc Med. 2002;2(suppl 2):S24-44.